series-b
Stage
1
Investors
About
Synpromics develops synthetic promoters to control gene expression, enabling precision gene therapies and advanced biotechnology applications.
Explore Synpromics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.